Shareholders Equity (Quarterly) Chart

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2025 9.587M
June 30, 2025
March 31, 2025
December 31, 2024
September 30, 2024 1.398M
June 30, 2024 2.511M
March 31, 2024 4.022M
December 31, 2023 32.00M
September 30, 2023 67.66M
June 30, 2023 73.31M
March 31, 2023 76.04M
December 31, 2022 168.94M
September 30, 2022 178.43M
June 30, 2022 120.68M
March 31, 2022 121.20M
December 31, 2021 125.79M
September 30, 2021 127.14M
June 30, 2021 127.71M
March 31, 2021 101.45M
December 31, 2020 104.94M
September 30, 2020 102.23M
June 30, 2020 102.65M
March 31, 2020 96.53M
December 31, 2019 98.57M
September 30, 2019 98.25M
Date Value
June 30, 2019 98.22M
March 31, 2019 99.67M
December 31, 2018 8.979M
September 30, 2018 9.229M
June 30, 2018 9.436M
March 31, 2018 9.619M
December 31, 2017 171.60M
September 30, 2017 237.64M
June 30, 2017 159.43M
March 31, 2017 59.59M
December 31, 2016 39.64M
September 30, 2016 45.65M
June 30, 2016 11.69M
March 31, 2016 10.27M
December 31, 2015 8.052M
September 30, 2015 6.230M
June 30, 2015 7.163M
March 31, 2015 2.660M
December 31, 2014 2.795M
September 30, 2014 1.615M
June 30, 2014 1.747M
March 31, 2014 2.393M
December 31, 2013 4.251M
September 30, 2013 3.248M
June 30, 2013 3.596M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -199.08M
Amgen, Inc. 11.69B
Anika Therapeutics, Inc. 137.28M
BioCryst Pharmaceuticals, Inc. -454.29M
Compugen Ltd. 88.73M